Xin Xue

7PUBLICATIONS
5CO-AUTHORS
Molecular targetsBioinformatic methods developmentBiologically active moleculesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 26, 2026
A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer.

|Dec 02, 2024
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery.

Tian-Hua Wei, Shuang-Shuang Zhou, Xiao-Long Jing

|Nov 15, 2024
Discovery of 1-(Phenylsulfonyl)-1,2,3,4-tetrahydroquinoline Derivative as Orally Bioavailable and Safe RORγt Inverse Agonists for Potential Treatment of Rheumatoid Arthritis.

Shan-Liang Sun, Hong-Jiang Xu, Xiao-Long Jiang

|Sep 11, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations.

Tian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu

|Mar 14, 2024
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.

Zi-Xuan Wang, Qing-Qing Li, Jiao Cai

|Mar 05, 2024
Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.

Yan-Cheng Yu, Zhen-Jiang Tong, Xiao-Ting Liang

Pageof 2

Frequent Collaborators

7 joint publications

Nianguang Li

6 joint publications

Yan-Cheng Yu

4 joint publications

Xiao-Long Wang

1 joint publications

Peng Cao